References
1. Kivity, S., et al., Infections and autoimmunity–friends or foes? Trends Immunol, 2009. 30 (8): p. 409-14.
2. Dalakas, M.C., Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing. Neurol Neuroimmunol Neuroinflamm, 2020.7 (5).
3. Sheikh, A.B., et al., Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review. J Neuroimmunol, 2021. 355 : p. 577577.
4. Bhattacharjee, S. and M. Banerjee, Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review. SN Compr Clin Med, 2020: p. 1-11.
5. Vlachoyiannopoulos, P.G., et al., Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis, 2020. 79 (12): p. 1661-1663.
6. Borghi, M.O., et al., Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome.Front Immunol, 2020. 11 : p. 584241.
7. Galeano-Valle, F., et al., Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism. Thromb Res, 2020. 192 : p. 113-115.
8. Bastard, P., et al., Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science, 2020.370 (6515).
9. Wang, E.Y., et al., Diverse Functional Autoantibodies in Patients with COVID-19. medRxiv, 2020.
10. Perez-Toledo, M., et al., Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with Paediatric Inflammatory Multi-System Syndrome. medRxiv, 2020.
11. Consiglio, C.R., et al., The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell, 2020.183 (4): p. 968-981.e7.
12. Gruber, C.N., et al., Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C). Cell, 2020. 183 (4): p. 982-995.e14.
13. Kreye, J., S.M. Reincke, and H. Prüss, Do cross-reactive antibodies cause neuropathology in COVID-19? Nat Rev Immunol, 2020.20 (11): p. 645-646.
14. Williamson, E.J., et al., Factors associated with COVID-19-related death using OpenSAFELY. Nature, 2020.584 (7821): p. 430-436.
15. Nalbandian, A., et al., Post-acute COVID-19 syndrome. Nat Med, 2021. 27 (4): p. 601-615.
16. Brandini, D.A., et al., Covid-19 and oral diseases: Crosstalk, synergy or association? Rev Med Virol, 2021.
17. Rekhtman, S., et al., Eruptions and related clinical course among 296 hospitalized adults with confirmed COVID-19. J Am Acad Dermatol, 2021. 84 (4): p. 946-952.
18. Swann, O.V., et al., Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. Bmj, 2020.370 : p. m3249.